The most popular, comprehensive and up-to-date medicine online.
|
|
Recent News
11/14/08 High blood pressure a looming problem for Europe
More than half of people diagnosed with high blood pressure do not have it under control and many more go undiagnosed, according to research carried out at the University of Warwick. 11/14/08 Light triggers a new chemical code for brain cells Brain cells can adopt a new chemical code in response to cues from the outside world, scientists working with tadpoles at the University of California, San Diego report in the journal Nature this week. 11/14/08 State mandates for HPV vaccination unwarranted and unwise The HPV vaccine, sold as Gardasil in the U.S., is intended to prevent four strains of the human papillomavirus, the most common sexually transmitted infection in the world.
HIV InfectionHIV: Acronym for the Human Immunodeficiency Virus, the cause of AIDS (acquired immunodeficiency syndrome). HIV has also been called the human lymphotropic virus type III, the lymphadenopathy-associated virus and the lymphadenopathy virus. No matter what name is applied, it is a retrovirus. (A retrovirus has an RNA genome and a reverse transcriptase enzyme. Using the reverse transcriptase, the virus uses its RNA as a template for making complementary DNA which can integrate into the DNA of the host organism). HIV infection, acute: The body's initial reaction to infection by the HIV virus. Acute HIV infection is a flu-like syndrome that occurs immediately after a person contracts HIV (the human immunodeficiency virus 1, the agent that causes AIDS). The syndrome is characterized by fever, sore throat, headache, skin rash and swollen glands (lymphadenopathy). This syndrome precedes seroconversion -- the development of detectable antibodies to HIV in the blood as a result of the infection. It normally takes several weeks to several months for antibodies to the virus to develop after HIV transmission. When antibodies to HIV appear in the blood, a person will test positive in the standard ELISA test for HIV. Category NewsResults from the Step study, a test-of-concept efficacy study of a Merck & Co., Inc. HIV vaccine candidate, were published online in two papers in The Lancet this week. Access to antiretroviral therapy for advanced HIV infection in low- and middle-income countries continued to grow throughout 2006, with more than two million people living with HIV/AIDS receiving treatment in December 2006, a 54% increase over the 1.3 mi Following a meeting of experts and other representatives in Switzerland earlier this month the World Health Organization (WHO) and the joint United Nations Programme on HIV/AIDS (UNAIDS) have announced that male circumcision should be part of the s AIDS Healthcare Foundation (AHF), the largest AIDS healthcare, prevention and education provider in the United States which operates free AIDS treatment clinics in the US, Africa, Latin Ameri... Research recently conducted in Kenya and Uganda is said to show conclusively that circumcised men are half as likely to become infected with the HIV virus through heterosexual sex than non-circumcised men. This confirms the findings of an earl |
